Dong-A Socio Holdings Co., Ltd. (KRX:000640)

South Korea flag South Korea · Delayed Price · Currency is KRW
113,900
-1,100 (-0.96%)
At close: Jun 5, 2025, 3:30 PM KST
15.02%
Market Cap 733.03B
Revenue (ttm) 1.36T
Net Income (ttm) 68.06B
Shares Out 6.44M
EPS (ttm) 10,569.52
PE Ratio 10.78
Forward PE 7.88
Dividend 1,650.49 (1.45%)
Ex-Dividend Date Jun 27, 2025
Volume 8,749
Average Volume 12,022
Open 115,300
Previous Close 115,000
Day's Range 112,300 - 115,900
52-Week Range 90,583 - 124,757
Beta 0.04
RSI 77.02
Earnings Date Jul 29, 2025

About Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical tri... [Read more]

Sector Healthcare
Founded 1932
Employees 5,530
Stock Exchange Korea Stock Exchange
Ticker Symbol 000640
Full Company Profile

Financial Performance

In 2024, Dong-A Socio Holdings's revenue was 1.33 trillion, an increase of 17.78% compared to the previous year's 1.13 trillion. Earnings were 58.02 billion, an increase of 0.06%.

Financial Statements

News

There is no news available yet.